Institutional Investing / Macro Insights
Health Care Outlook
This piece explores our outlook for the Health Care sector, highlighting the key political and sentiment trends shaping the industry and the investment case for favouring large-cap Biopharmaceuticals and small and mid-cap Biotech firms.
See Our Institutional Insights
Stay on top of the latest investment trends and developments with our views and research.